Evidence supporting the use of: Tea Tree
For the health condition: Impetigo

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Tea tree oil (Melaleuca alternifolia) has been studied for its antimicrobial properties, which form the basis for its suggested use in supporting the treatment of impetigo—a superficial bacterial skin infection most often caused by Staphylococcus aureus or Streptococcus pyogenes. Several in vitro studies have demonstrated that tea tree oil exhibits significant antibacterial activity against these pathogens. For example, tea tree oil’s major component, terpinen-4-ol, has been shown to disrupt bacterial cell membranes and inhibit the growth of both staphylococci and streptococci. However, clinical evidence directly supporting the efficacy of tea tree oil in treating impetigo in humans is limited. While some small clinical trials and case reports suggest potential benefits in treating superficial skin infections, including impetigo, these studies are often limited by small sample sizes, lack of blinding, or absence of direct comparison with standard antibiotic treatments. Major dermatological guidelines do not currently recommend tea tree oil as a first-line or adjunct therapy for impetigo, primarily due to the lack of robust randomized controlled trials. In summary, while laboratory evidence supports the antibacterial properties of tea tree oil against the causative agents of impetigo, clinical evidence in humans remains modest and preliminary. Tea tree oil may offer some benefit, but it should not replace established antibiotic therapies without further high-quality clinical research.

More about Tea Tree
More about Impetigo

Products containing Tea Tree

We currently have no products on Vitabase that contain this ingredient.